Cancer antigens CEA and CA19–9 are the two most common colon cancer markers [29], used not only for preoperative assessment of extent and outcome of the disease, but also for monitoring recurrence after surgery. The gene discussed is CEACAM5; the disease is malignant colon neoplasm.